Prostate Cancer
Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients - Abstract
January 10, 2013
The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients - Abstract
January 10, 2013
Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased? - Abstract
January 10, 2013
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study - Abstract
January 10, 2013
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: The ProtecT study - Abstract
January 9, 2013
Experience in reducing intraoperative blood loss in radical retropubic prostatectomy - Abstract
January 8, 2013
The relationship between nutrition and prostate cancer: Is more always better? - Abstract
January 8, 2013
Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities - Abstract
January 8, 2013
Does quality of life of prostate cancer patients differ by stage and treatment? - Abstract
January 8, 2013
Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer - Abstract
January 8, 2013
Treatment patterns for prostate cancer: Comparison of medicare claims data to medical record review - Abstract
January 8, 2013